Dealing with dementia: obstacles or opportunities?

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

Subscribe to our newsletter and stay up to date with the latest news.

: ArchiMed acquires Eurolyser Diagnostica
[#Congratulations](https://www.linkedin.com/feed/hashtag/?keywords=%23Congratulations) to our client ArchiMed on their acquisition of Eurolyser Diagnostica, a fast- growing [#Austrian](https://www.linkedin.com/feed/hashtag/?keywords=%23Austrian) [#IVD](https://www.linkedin.com/feed/hashtag/?keywords=%23IVD) player. The announcement follows ArchiMed's investment in Italy-based DIESSE diagnostica senese SpA, and marks the fund's second investment in the IVD space this year. Eurolyser Diagnostica's [#pointofcare](https://www.linkedin.com/feed/hashtag/?keywords=%23pointofcare) platform serves three distinct end markets: [#medical](https://www.linkedin.com/feed/hashtag/?keywords=%23medical) diagnostics, [#veterinary](https://www.linkedin.com/feed/hashtag/?keywords=%23veterinary) diagnostics, and [#food](https://www.linkedin.com/feed/hashtag/?keywords=%23food) & [#feed](https://www.linkedin.com/feed/hashtag/?keywords=%23feed). The business has grown from distinct leadership positions in both [hashtag#medical](https://www.linkedin.com/feed/hashtag/?keywords=%23medical) and [#veterinary](https://www.linkedin.com/feed/hashtag/?keywords=%23veterinary) mono tests, and it will be interesting to see how management is challenging the status quo of incumbents such as Orion Diagnostica Oy, IDEXX, and Abaxis, Inc.

: Investing in Cancer Immunotherapy
Dr **Michelle Tempest** and Dr **Karen Sayal** reveal in this July 2019 **#LaingBuisson** article promising opportunities investing in **#immunotherapy** treatments

: Candesic supports the $450m sale of Blue Earth Diagnostics to Bracco Group
Congratulations to Blue Earth Diagnostics' CEO [jonathan allis](https://www.linkedin.com/in/ACoAAAL4wkMB23NkTCX2n8urTX8E_6Pf32lQDdI/) and the management team on this $450M deal. Candesic is proud to have been part of this journey and looking forward to see the business grow under [#Bracco](https://www.linkedin.com/feed/hashtag/?keywords=%23Bracco)'s new ownership. Candesic provided vendor side due diligence to Blue earth diagnostics.